Literature DB >> 8588655

Alteration of epidermal differentiation in middle ear cholesteatoma.

M Stammberger1, J Bujía, E Kastenbauer.   

Abstract

This immunohistologic study was undertaken to compare the localization of markers of epidermal differentiation in cholesteatoma and normal external ear canal skin. Both basal cells and suprabasal cell layers of cholesteatoma exhibit an abnormal distribution of differentiation markers (involucrin, filaggrin, glycoproteins detected by monoclonal antibodies J143 [alpha3 integrin chain] and T16 [Trop-2]). The immunostaining intensity of filaggrin and involucrin was higher in cholesteatoma than in external ear canal skin. In cholesteatoma, involucrin was localized in the cytoplasm of the suprabasal cells, and particularly in spinous cells, it appeared earlier than in ear canal skin. Filaggrin was noted in the cytoplasm of the granular and cornified cells in both tissues. The J143 reactive integrin, very late antigen 3 (VLA-3), which in normal epidermis is confined to the basal cells, was also seen in spinous and granular cell layers of cholesteatoma. Furthermore, the immunostaining for VLA-3 in the basal cell layer of cholesteatoma was stronger than in normal epidermis. In contrast to this, expression of Trop-2, which is preferentially found in the suprabasal cell layers, particularly in granular cells of normal epidermis, was clearly reduced in cholesteatoma. These results demonstrate complex alterations in the differentiation of the keratinocytes in cholesteatoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8588655

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  5 in total

1.  Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.

Authors:  A Holly; M Sittinger; J Bujia
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

2.  Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.

Authors:  Hans-J Welkoborsky; Roland S Jacob; Mike L Hinni
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-06-01       Impact factor: 2.503

3.  Carrier status for the common R501X and 2282del4 filaggrin mutations is not associated with hearing phenotypes in 5,377 children from the ALSPAC cohort.

Authors:  Santiago Rodriguez; Amanda J Hall; Raquel Granell; W H Irwin McLean; Alan D Irvine; Colin N A Palmer; George Davey Smith; John Henderson; Ian N M Day
Journal:  PLoS One       Date:  2009-06-03       Impact factor: 3.240

4.  Comparative analysis of the expression of involucrin, filaggrin and cytokeratin 4, 10, 16 in cholesteatoma.

Authors:  Hyun Jung Min; Chul Won Park; Jin Hyeok Jeong; Seok Hyun Cho; Kyung Rae Kim; Seung Hwan Lee
Journal:  Korean J Audiol       Date:  2012-12-18

5.  Identification of altered protein abundances in cholesteatoma matrix via mass spectrometry-based proteomic analysis.

Authors:  Derrick R Randall; Phillip S Park; Justin K Chau
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-11-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.